The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index.

Diversification via an ETF can help biotech investors avoid boom-or-bust volatility while still capitalizing on long-term growth trends.

A 100% tariff on imported drugs just expanded to cover every drugmaker in the country, yet the biotech market's most closely ...

Biotech firms have been increasingly directing capital toward oncology therapeutics in recent years, reflecting a structural shift as companies recognize the significant commercial potential of ...

Vanguard Health Care ETF offers a significantly lower expense ratio and higher dividend yield than iShares Biotechnology ETF. iShares' ETF has delivered stronger one-year total returns but carries ...

The biotech sector is heading into the third-quarter earnings season with a tug-of-war between higher interest rates and an ...

In addition to the reversion trade factors, the sector has benefited from the steady move down in interest rates in 2025. This has been a tailwind for higher beta areas of the small caps, like small ...

The investment seeks to provide long-term capital appreciation. The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in the securities of ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Scientists meticulously analyze complex data on a monitor ...

VanEck Biotech ETF is a Buy, offering concentrated exposure to leading biotech firms entering a new growth cycle. BBH’s top holdings—Amgen, Gilead, and Vertex—drive capital appreciation through ...

ETF news. Track expert coverage of price movements, fund changes, and market factors. Set free alerts to stay ahead.

The fund is sponsored by Van Eck. It has amassed assets over $462.7 million, making it one of the average sized ETFs attempting to match the performance of the Healthcare - Biotech segment of the ...